UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review

Curēus (Palo Alto, CA), 2022-07

2022

Volltextzugriff (PDF)

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4787-4792

2009

Volltextzugriff (PDF)

nab -Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

Frontiers in oncology, 2021-01, Vol.10, p.485587-485587

2021

Volltextzugriff (PDF)

Epithelial–mesenchymal transition in pulmonary carcinosarcoma: case report and literature review

Therapeutic Advances in Medical Oncology, 2012-01, Vol.4 (1), p.31-37

2012

Volltextzugriff (PDF)

Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast

Advances in therapy, 2023-12, Vol.40 (12), p.5567-5578

2023

Volltextzugriff (PDF)

Comprehensive genomic profiling: Insights into diagnostic value and treatment strategy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15028-e15028

2022

Volltextzugriff (PDF)

Clinical activity and safety of naptumomab estafenatox (NAP) and docetaxel in patients (pts) with checkpoint inhibitor (CPI) –pretreated advanced/metastatic non-small cell lung cancer (NSCLC): Preliminary results of a P2 trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8615-8615

2024

Volltextzugriff (PDF)

BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.326-330

2014

Volltextzugriff (PDF)

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.327-333

2021

Volltextzugriff (PDF)

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer

Cancer discovery, 2016-06, Vol.6 (6), p.601-611

2016

Volltextzugriff (PDF)

Immunotherapy brings new hope for patients with NSCLC

The Journal of community and supportive oncology, 2015-09, Vol.13 (9), p.310-311

2015

Volltextzugriff (PDF)

Randomized phase II study of pembrolizumab (P) alone versus pegilodecakin (PEG) in combination with P as first-line (1L) therapy in patients (pts) with stage IV non-small cell lung cancer (NSCLC) with high PD-L1 expression (CYPRESS 1)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9563-9563

2020

Volltextzugriff (PDF)

Clinical decision support tools (CDST) provide education at the point-of-care to assist provider treatment choices

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19165-e19165

2020

Volltextzugriff (PDF)

Phase III trial of sitravatinib plus nivolumab vs. docetaxel for treatment of NSCLC after platinum-based chemotherapy and immunotherapy (SAPPHIRE)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS9635-TPS9635

2020

Volltextzugriff (PDF)

ABOUND.70+: Safety and efficacy of nab -paclitaxel/carboplatin ( nab -P/C) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9059-9059

2017

Volltextzugriff (PDF)

Abstract C71: Phase II study of maintenance therapy with pazopanib or pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following platinum-based chemotherapy

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C71-C71

2013

Volltextzugriff (PDF)

Abstract CT229: CRESTONE: A Phase 2 study of seribantumab in adult patients with neuregulin-1 (NRG1) fusion positive locally advanced or metastatic solid tumors

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT229-CT229

2023

Volltextzugriff (PDF)

P2.03a-039 ABOUND.70+: Interim Quality of Life (QoL) Results of nab-Paclitaxel/Carboplatin Treatment of Elderly Patients With NSCLC: Topic: Clinical Trials

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S911-S912

2017

Volltextzugriff (PDF)

P2.03a-039 ABOUND.70+: Interim Quality of Life (QoL) Results of nab-Paclitaxel/Carboplatin Treatment of Elderly Patients With NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S911-S912

2017

Volltextzugriff (PDF)

P2.03a-046 Safety and Efficacy Results From ABOUND.70+: nab-Paclitaxel/Carboplatin in Elderly Patients With Advanced NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S916-S917

2017

Volltextzugriff (PDF)

P2.03a-046 Safety and Efficacy Results From ABOUND.70+: nab-Paclitaxel/Carboplatin in Elderly Patients With Advanced NSCLC: Topic: Clinical Trials

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S916-S917

2017

Volltextzugriff (PDF)

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

Frontiers in oncology, 2018-07, Vol.8, p.262-262

2018

Volltextzugriff (PDF)

Comprehensive genomic profiling (CGP) of advanced cancers to identify MET exon 14 alterations that confer sensitivity to MET inhibitors

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11007-11007

2015

Volltextzugriff (PDF)

Ectopic Adrenocorticotropic Hormone Syndrome: A Diagnostic Challenge and Review of the Literature

Proceedings - Baylor University. Medical Center, 2010-10, Vol.23 (4), p.426-428

2010

Volltextzugriff (PDF)

Chest Wall Chondrosarcoma

Proceedings - Baylor University. Medical Center, 2009-10, Vol.22 (4), p.362-365

2009

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Oncology
(10)
Humans
(6)
Lung Neoplasms - Drug Therapy
(4)
Middle Aged
(4)
Departments
(3)
Diagnosis
(3)
Female
(3)
Lung Neoplasms - Diagnosis
(3)
Lung Neoplasms - Genetics
(3)
Male
(3)
Tumors
(3)
Advanced Non-Small Cell Lung Cancer
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Biomarkers
(2)
Care And Treatment
(2)
Case Reports
(2)
Case Studies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

nab -Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

Epithelial–mesenchymal transition in pulmonary carcinosarcoma: case report and literature review

Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast

Comprehensive genomic profiling: Insights into diagnostic value and treatment strategy

Clinical activity and safety of naptumomab estafenatox (NAP) and docetaxel in patients (pts) with checkpoint inhibitor (CPI) –pretreated advanced/metastatic non-small cell lung cancer (NSCLC): Preliminary results of a P2 trial

BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer

Immunotherapy brings new hope for patients with NSCLC

Randomized phase II study of pembrolizumab (P) alone versus pegilodecakin (PEG) in combination with P as first-line (1L) therapy in patients (pts) with stage IV non-small cell lung cancer (NSCLC) with high PD-L1 expression (CYPRESS 1)

Clinical decision support tools (CDST) provide education at the point-of-care to assist provider treatment choices

Phase III trial of sitravatinib plus nivolumab vs. docetaxel for treatment of NSCLC after platinum-based chemotherapy and immunotherapy (SAPPHIRE)

ABOUND.70+: Safety and efficacy of nab -paclitaxel/carboplatin ( nab -P/C) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)

Abstract C71: Phase II study of maintenance therapy with pazopanib or pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following platinum-based chemotherapy

Abstract CT229: CRESTONE: A Phase 2 study of seribantumab in adult patients with neuregulin-1 (NRG1) fusion positive locally advanced or metastatic solid tumors

P2.03a-039 ABOUND.70+: Interim Quality of Life (QoL) Results of nab-Paclitaxel/Carboplatin Treatment of Elderly Patients With NSCLC: Topic: Clinical Trials

P2.03a-039 ABOUND.70+: Interim Quality of Life (QoL) Results of nab-Paclitaxel/Carboplatin Treatment of Elderly Patients With NSCLC

P2.03a-046 Safety and Efficacy Results From ABOUND.70+: nab-Paclitaxel/Carboplatin in Elderly Patients With Advanced NSCLC

P2.03a-046 Safety and Efficacy Results From ABOUND.70+: nab-Paclitaxel/Carboplatin in Elderly Patients With Advanced NSCLC: Topic: Clinical Trials

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

Comprehensive genomic profiling (CGP) of advanced cancers to identify MET exon 14 alterations that confer sensitivity to MET inhibitors

Ectopic Adrenocorticotropic Hormone Syndrome: A Diagnostic Challenge and Review of the Literature

Chest Wall Chondrosarcoma

Suchergebnisse filtern